secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tevogen Bio Holdings Inc. (TVGN)
CIK:        0001860871
Form:       8-K
Filed at:   2025-07-10T23:59:59+00:00
Accession:  0001641172-25-018533
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Tevogen Bio grants 8M restricted shares to CEO; total outstanding 193.7M shares
-------------------------------------------------------------------------------

- Board approved restricted stock awards on June 27, 2025, including 8M shares to CEO Dr. Ryan Saadi.
- Total outstanding shares now 193,693,433.
- CEO's shares vest in four equal annual installments starting on the seventh anniversary of grant.
- Other grantees' shares vest in three equal annual installments starting on the fifth anniversary.
- Shares subject to forfeiture if continuous service not maintained; cannot be transferred before vesting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860871/000164117225018533/0001641172-25-018533-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860871/000164117225018533/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-018533

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer